Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01791959

The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

The Effects of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Sponsor: National Nutrition and Food Technology Institute

Conditions Non Alcoholic Steatohepatitis

Interventions placebo synbiotic

Updated 5 times since 2017 Last updated: Feb 12, 2013 Started: Mar 31, 2012 Primary completion: Oct 31, 2012 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01791959, this PHASE2/PHASE3 trial focuses on Non Alcoholic Steatohepatitis and remains completed. Sponsored by National Nutrition and Food Technology Institute, it has been updated 5 times since 2012, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Nutrition and Food Technology Institute

Data source: National Nutrition and Food Technology Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.